Empowered Funds, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Empowered Funds, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2021$1,480,000
-64.9%
12,741
-33.0%
0.19%
-29.1%
Q2 2021$4,216,000
+261.6%
19,008
+37.3%
0.27%
+3.5%
Q1 2020$1,166,000
-50.0%
13,840
-50.0%
0.26%
-42.2%
Q4 2019$2,332,000
+137.5%
27,680
+110.8%
0.45%
+4.9%
Q3 2019$982,000
-25.8%
13,133
-37.3%
0.43%
-22.8%
Q2 2019$1,324,000
+0.4%
20,936
-23.6%
0.55%
+17.2%
Q1 2019$1,319,00027,3910.47%
Other shareholders
NOVOCURE LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders